Compare Nerdwallet Inc (NRDS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

NerdWallet (NRDS) trades at $9.56, down 3.24% today, amid a bearish technical signal. The stock shows strong fundamentals with a low P/E of 10.4 and P/S of 0.78, alongside robust revenue growth from $539M in 2022 to $837M in 2025. Recent Q2 2026 earnings missed estimates at $0.07 per share, but Q1 and Q4 2025 beat expectations. Operating cash flow improved to $132M in 2025, though net cash flow turned negative in 2026 projections.

Outlook is mixed: valuation metrics suggest upside potential, with a 66.7% analyst buy rating and a 27.9% price target upside per Zacks (August 10, 2026). However, technical weakness and Q2 earnings miss pose near-term risks. Key catalysts include continued revenue growth and margin expansion, but reliance on organic search traffic remains a headwind.

XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.

Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.